Annual Accounts Payable
$6.56 M
-$16.37 M-71.39%
December 31, 2024
Summary
- As of March 14, 2025, DYN annual accounts payable is $6.56 million, with the most recent change of -$16.37 million (-71.39%) on December 31, 2024.
- During the last 3 years, DYN annual accounts payable has risen by +$2.53 million (+62.79%).
- DYN annual accounts payable is now -71.39% below its all-time high of $22.94 million, reached on December 31, 2023.
Performance
DYN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.56 M
+$405.00 K+6.58%
December 31, 2024
Summary
- As of March 14, 2025, DYN quarterly accounts payable is $6.56 million, with the most recent change of +$405.00 thousand (+6.58%) on December 31, 2024.
- Over the past year, DYN quarterly accounts payable has increased by +$4.67 million (+247.38%).
- DYN quarterly accounts payable is now -71.39% below its all-time high of $22.94 million, reached on December 31, 2023.
Performance
DYN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DYN Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.4% | +247.4% |
| 3 y3 years | +62.8% | +140.9% |
| 5 y5 years | +422.4% | +140.9% |
DYN Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.4% | +62.8% | -71.4% | +614.0% |
| 5 y | 5-year | -71.4% | +422.4% | -71.4% | +614.0% |
| alltime | all time | -71.4% | +1166.8% | -71.4% | +614.0% |
Dyne Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $6.56 M(-71.4%) | $6.56 M(+6.6%) |
| Sep 2024 | - | $6.16 M(+225.9%) |
| Jun 2024 | - | $1.89 M(-73.8%) |
| Mar 2024 | - | $7.21 M(-68.5%) |
| Dec 2023 | $22.94 M(+336.1%) | $22.94 M(+545.5%) |
| Sep 2023 | - | $3.55 M(+30.4%) |
| Jun 2023 | - | $2.72 M(-68.9%) |
| Mar 2023 | - | $8.77 M(+66.8%) |
| Dec 2022 | $5.26 M | $5.26 M(+472.3%) |
| Sep 2022 | - | $919.00 K(-86.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $6.97 M(+34.4%) |
| Mar 2022 | - | $5.19 M(+28.7%) |
| Dec 2021 | $4.03 M(+17.2%) | $4.03 M(-43.1%) |
| Sep 2021 | - | $7.09 M(+25.5%) |
| Jun 2021 | - | $5.65 M(-1.9%) |
| Mar 2021 | - | $5.76 M(+67.4%) |
| Dec 2020 | $3.44 M(+173.9%) | $3.44 M(+131.2%) |
| Sep 2020 | - | $1.49 M(-32.1%) |
| Jun 2020 | - | $2.19 M(+74.5%) |
| Dec 2019 | $1.26 M(+142.5%) | $1.26 M |
| Dec 2018 | $518.00 K | - |
FAQ
- What is Dyne Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Dyne Therapeutics?
- What is Dyne Therapeutics annual accounts payable year-on-year change?
- What is Dyne Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly accounts payable year-on-year change?
What is Dyne Therapeutics annual accounts payable?
The current annual accounts payable of DYN is $6.56 M
What is the all time high annual accounts payable for Dyne Therapeutics?
Dyne Therapeutics all-time high annual accounts payable is $22.94 M
What is Dyne Therapeutics annual accounts payable year-on-year change?
Over the past year, DYN annual accounts payable has changed by -$16.37 M (-71.39%)
What is Dyne Therapeutics quarterly accounts payable?
The current quarterly accounts payable of DYN is $6.56 M
What is the all time high quarterly accounts payable for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly accounts payable is $22.94 M
What is Dyne Therapeutics quarterly accounts payable year-on-year change?
Over the past year, DYN quarterly accounts payable has changed by +$4.67 M (+247.38%)